Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season

被引:111
作者
Belongia, Edward A. [1 ]
Sundaram, Maria E. [1 ]
McClure, David L. [1 ]
Meece, Jennifer K. [1 ]
Ferdinands, Jill [2 ,3 ]
VanWormer, Jeffrey J. [1 ]
机构
[1] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA
[2] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA
[3] Battelle Mem Inst, Atlanta, GA USA
关键词
Influenza; Influenza vaccine; Immunity; Vaccine effectiveness; EFFICACY; ANTIBODY;
D O I
10.1016/j.vaccine.2014.06.052
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Recent studies have suggested that vaccine-induced protection against influenza may decline within one season. We reanalyzed data from a study of influenza vaccine effectiveness to determine if time since vaccination was an independent predictor of influenza A (H3N2). Methods: Patients with acute respiratory illness were actively recruited during the 2007-2008 season. Respiratory swabs were tested for influenza, and vaccination dates were determined by a validated immunization registry. The association between influenza RT-PCR result and vaccination interval (days) was examined using multivariable logistic regression, adjusting for calendar time, age and other confounders. Results: There were 629 vaccinated participants, including 177 influenza A (H3N2) cases and 452 test negative controls. The mean (SD) interval from vaccination to illness onset was 101.7 (25.9) days for influenza cases and 93.0 (29.9) days for controls. There was a significant association between vaccination interval and influenza result in the main effects model. The adjusted odds ratio (a0R) for influenza was 1.12 (CI 1.01, 1.26) for every 14 day increase in the vaccination interval. Age modified the association between vaccination interval and influenza (p = 0.005 for interaction). Influenza was associated with increasing vaccination interval in young children and older adults, but not in adolescents or non-elderly adults. Similar results were found when calendar week of vaccine receipt was assessed as the primary exposure variable. Conclusions: Identification of influenza A (H3N2) was associated with increasing time since vaccination among young children and older adults during a single influenza season. (C) 2014 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 50 条
  • [41] Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States
    Newall, A. T.
    Chen, C.
    Wood, J. G.
    Stockwell, M. S.
    VACCINE, 2018, 36 (39) : 5910 - 5915
  • [42] Antigenic variation of the human influenza A (H3N2) virus during the 2014–2015 winter season
    Sha Hua
    XiYan Li
    Mi Liu
    YanHui Cheng
    YouSong Peng
    WeiJuan Huang
    MinJu Tan
    HeJiang Wei
    JunFeng Guo
    DaYan Wang
    AiPing Wu
    YueLong Shu
    TaiJiao Jiang
    Science China Life Sciences, 2015, 58 : 882 - 888
  • [43] Antigenic variation of the human influenza A(H3N2) virus during the 2014–2015 winter season
    HUA Sha
    LI XiYan
    LIU Mi
    CHENG YanHui
    PENG YouSong
    HUANG WeiJuan
    TAN MinJu
    WEI HeJiang
    GUO JunFeng
    WANG DaYan
    WU AiPing
    SHU YueLong
    JIANG TaiJiao
    Science China(Life Sciences) , 2015, (09) : 882 - 895
  • [44] Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets
    Music, Nedzad
    Tzeng, Wen-Pin
    Gross, F. Liaini
    Levine, Min Z.
    Xu, Xiyan
    Shieh, Wun-Ju
    Tumpey, Terrence M.
    Katz, Jacqueline M.
    York, Ian A.
    NPJ VACCINES, 2019, 4
  • [45] Whole-genome sequences of influenza A(H3N2) viruses isolated from Brazilian patients with mild illness during the 2014 season
    Resende, Paola Cristina
    Motta, Fernando Couto
    Born, Priscila Silva
    Miranda, Milene
    Siqueira, Marilda M.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2015, 110 (01): : 148 - 150
  • [46] Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023
    Murphy, Caitriona
    Kwan, Mike Y. W.
    Chan, Eunice L. Y.
    Wong, Joshua S. C.
    Sullivan, Sheena G.
    Peiris, Malik
    Cowling, Benjamin J.
    Lee, So-Lun
    VACCINE, 2024, 42 (08) : 1878 - 1882
  • [47] Partial Protection Induced by 2011-2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People
    Camilloni, Barbara
    Basileo, Michela
    Menculini, Giuseppe
    Tozzi, Paolo
    Iorio, Anna Maria
    ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 1, 2016, 897 : 45 - 53
  • [48] Adjuvant potency of Astragaloside VII embedded cholesterol nanoparticles for H3N2 influenza vaccine
    Genc, Rukan
    Yakubogullari, Nilgun
    Nalbantsoy, Ayse
    Coven, Fethiye
    Bedir, Erdal
    TURKISH JOURNAL OF BIOLOGY, 2020, 44 (05) : 304 - 314
  • [49] M2-Deficient Single-Replication Influenza Vaccine-Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain
    Eiden, Joseph
    Volckaert, Bram
    Rudenko, Oleg
    Aitchison, Roger
    Herber, Renee
    Belshe, Robert
    Greenberg, Harry
    Coelingh, Kathleen
    Marshall, David
    Kawaoka, Yoshihiro
    Neumann, Gabriele
    Bilsel, Pamuk
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (01) : 83 - 90
  • [50] Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015
    Skowronski, Danuta M.
    Chambers, Catharine
    De Serres, Gaston
    Sabaiduc, Suzana
    Winter, Anne-Luise
    Dickinson, James A.
    Gubbay, Jonathan B.
    Fonseca, Kevin
    Drews, Steven J.
    Charest, Hugues
    Martineau, Christine
    Krajden, Mel
    Petric, Martin
    Bastien, Nathalie
    Li, Yan
    Smith, Derek J.
    JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (07) : 1059 - 1069